President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment
Squawk Pod5 Loka 2020

President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment

President Trump remains at Walter Reed National Military Medical Center, and treatments for his coronavirus diagnosis include an experimental antibody cocktail from Regeneron, dexamethasone, and Gilead’s remdesivir. CNBC’s Eamon Javers tracks the timeline of events since the President’s announcement, and CNBC’s Meg Tirrell explains the drugs in the President’s treatment plans. Former FDA Commissioner Dr. Scott Gottlieb deciphers the President’s likely condition from White House communications, and Regeneron CEO Dr. Leonard Schleifer discusses the status of the monoclonal antibody cocktail that was approved by the FDA for “compassionate use” in President Trump’s treatment.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1879)

Strong Tech Stocks, A Weak Jobs Report, & FDA Departures 8/1/25

Strong Tech Stocks, A Weak Jobs Report, & FDA Departures 8/1/25

President Trump has ratcheted up tariffs for dozens of countries set to take effect next week. Apple reported its greatest revenue growth in years, Microsoft’s market cap topped $4 trillion after its ...

1 Elo 202540min

5 Things to Know Before the Opening Bell 8/1/2025

5 Things to Know Before the Opening Bell 8/1/2025

The 5 things you need to know before the stock market opens today: shares of Coinbase and Roku are both tumbling after the companies reported quarterly results, but each stock is still up over 50% and...

1 Elo 20253min

Treasury Secretary Bessent & Media with Mario Gabelli 7/31/25

Treasury Secretary Bessent & Media with Mario Gabelli 7/31/25

After the U.S. struck a trade deal with South Korea, Treasury Secretary Scott Bessent explains that negotiation and the ongoing talks with China after the administration’s two-day meeting with Beijing...

31 Heinä 202558min

FDA Commissioner Dr. Marty Makary & U.S. Tourism 7/30/25

FDA Commissioner Dr. Marty Makary & U.S. Tourism 7/30/25

The morning after the FDA’s vaccine regulator Dr. Vinay Prasad announced his resignation, FDA Commissioner Dr. Marty Makary shares the agency’s position on the measles vaccine, Sarepta’s Duchenne ther...

30 Heinä 202542min

5 Things to Know Before the Opening Bell 7/30/2025

5 Things to Know Before the Opening Bell 7/30/2025

The 5 things you need to know before the stock market opens today: AI startup Anthropic is nearing a deal to raise as much as $5 billion in new funding. SoFi Technologies under pressure after announci...

30 Heinä 20252min

Commerce Secretary Lutnick & A Midtown Tragedy 7/29/25

Commerce Secretary Lutnick & A Midtown Tragedy 7/29/25

After a gunman killed 4 people in a New York City office building in midtown on Monday, corporate America is evaluating office security and employee safety. Former Boeing chief security officer and cu...

29 Heinä 202536min

Trade Talks: A Deal in the EU, Talks with China in Stockholm 7/28/25

Trade Talks: A Deal in the EU, Talks with China in Stockholm 7/28/25

Now that President Trump has struck a trade deal with the EU, attention shifts to Stockholm, where U.S. Trade Representative Jamieson Greer is participating in trade negotiations with China. He explai...

28 Heinä 202536min

5 Things to Know Before the Opening Bell 7/28/2025

5 Things to Know Before the Opening Bell 7/28/2025

The 5 things you need to know before the stock market opens today: Boeing expects its St. Louis area workers to strike next week, China has unveiled its global AI action plan, Union Pacific could be n...

28 Heinä 20251min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-rahamania
rss-lahtijat
inderespodi
ostan-asuntoja-podcast
rss-h-asselmoilanen
rss-paasipodi
herrasmieshakkerit
rahapuhetta
pomojen-suusta
sijoituspodi
rss-laakispodi
rss-bisnesta-bebeja
taloudellinen-mielenrauha
syo-nuku-saasta
asuntoasiaa-paivakirjat
rss-startup-ministerio